Range Low Price High Price Comment
30 days $34.24 $40.49 Monday, 29th Apr 2024 COLL stock ended at $36.71. This is 0.796% more than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 1.81% from a day low at $36.51 to a day high of $37.17.
90 days $31.34 $40.91
52 weeks $20.84 $40.91

Historical Collegium Pharmaceutical prices

Date Open High Low Close Volume
Jan 29, 2016 $16.25 $17.38 $16.13 $17.03 306 000
Jan 28, 2016 $16.31 $16.31 $15.27 $16.18 238 900
Jan 27, 2016 $16.98 $17.45 $16.21 $16.35 276 300
Jan 26, 2016 $17.27 $17.49 $16.10 $17.01 169 900
Jan 25, 2016 $16.95 $17.68 $16.83 $17.20 187 700
Jan 22, 2016 $16.67 $17.18 $16.10 $17.06 156 300
Jan 21, 2016 $16.21 $16.89 $15.74 $16.40 240 300
Jan 20, 2016 $14.45 $16.71 $14.37 $16.15 379 000
Jan 19, 2016 $15.94 $16.16 $14.46 $14.90 331 900
Jan 15, 2016 $15.70 $15.97 $14.90 $15.57 565 800
Jan 14, 2016 $15.17 $16.79 $13.80 $16.26 302 800
Jan 13, 2016 $17.93 $17.94 $14.41 $15.11 548 700
Jan 12, 2016 $18.84 $19.48 $17.39 $17.93 334 900
Jan 11, 2016 $19.86 $19.86 $17.79 $18.50 605 300
Jan 08, 2016 $20.00 $20.14 $19.17 $19.72 1 794 100
Jan 07, 2016 $23.37 $23.45 $21.01 $21.13 233 800
Jan 06, 2016 $23.65 $25.91 $23.04 $23.73 203 200
Jan 05, 2016 $25.96 $25.96 $22.90 $23.96 196 200
Click to get the best stock tips daily for free!

About Collegium Pharmaceutical

Collegium Pharmaceutical Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT